Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Reilley · SciRah

Researcher profile · Semantic Scholar

M. Reilley

Share profile

M. Reilley — researcher profile on SciRah

h-index: 12
Works: 29
Citations: 808

Most-cited papers

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.
M. Reilley, P. McCoon, C. Cook, P. Lyne +23 more
2018Journal of Immunotherapy for Cancer226 citations Open access
Semantic Scholar
Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity
C. Ager, M. Reilley, C. Nicholas, Todd Bartkowiak +2 more
2017Cancer immunology research161 citations Open access
Semantic Scholar
Activation of 4-1BB on liver myeloid cells triggers hepatitis via an interleukin-27 dependent pathway
Todd Bartkowiak, A. Jaiswal, C. Ager, Renee L Chin +7 more
2018Clinical Cancer Research90 citations Open access
Semantic Scholar
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
M. Reilley, Brittany Morrow, C. Ager, Arthur J. Liu +2 more
2019Journal of Immunotherapy for Cancer69 citations Open access
Semantic Scholar
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
M. Reilley, Ann M. Bailey, V. Subbiah, F. Janku +15 more
2017Journal of Immunotherapy for Cancer67 citations Open access
Semantic Scholar
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma
M. Katz, Gina R. Petroni, Todd W. Bauer, M. Reilley +15 more
2023Journal for ImmunoTherapy of Cancer35 citations Open access
Semantic Scholar
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
A. Coveler, M. Reilley, M. Zalupski, T. Macarulla +19 more
2024Clinical Cancer Research25 citations Open access
Semantic Scholar
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer
N. Segal, J. Tie, Scott Kopetz, M. Ducreux +12 more
2024British Journal of Cancer19 citations Open access
Semantic Scholar
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Lestat R. Ali, P. Lenehan, V. Cardot-Ruffino, Andressa Dias Costa +17 more
2023Clinical Cancer Research18 citations Open access
Semantic Scholar
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
C. Ager, M. Reilley, C. Nicholas, Todd Bartkowiak +496 more
2016Journal for ImmunoTherapy of Cancer18 citations Open access
Semantic Scholar
523 Preliminary clinical experience with XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors
Elaine Shum, M. Reilley, Y. Najjar, A. Daud +19 more
2021Journal for ImmunoTherapy of Cancer17 citations Open access
Semantic Scholar
Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer
Jonathan D. Sorah, D. Moore, M. Reilley, M. Salem +4 more
2022The Oncologist14 citations Open access
Semantic Scholar
Phase 1 trial of TLR9 agonist lefitolimod in combination with CTLA-4 checkpoint inhibitor ipilimumab in advanced tumors.
M. Reilley, A. Tsimberidou, S. Piha-Paul, T. Yap +12 more
2019Journal of Clinical Oncology12 citations
Semantic Scholar
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations
E. Hoskins, E. Samorodnitsky, M. Wing, J. Reeser +22 more
2023JCO Precision Oncology6 citations
Semantic Scholar
Safety and clinical activity of oleclumab (O) ± durvalumab (D) + chemotherapy (CT) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A phase 1b/2 randomized study.
A. Coveler, M. Reilley, M. Zalupski, T. Macarulla +16 more
2023Journal of Clinical Oncology5 citations
Semantic Scholar
Immunologic profiling of consensus molecular subtype (CMS) stratified colorectal cancer (CRC) primary and liver metastectomy specimens: Implications for immune targeting of proficient mismatch repair CRC.
M. Reilley, J. Blando, R. Katkhuda, D. Menter +5 more
20165 citations
Semantic Scholar
160P COLUMBIA-1: A phase Ib/II, open-label, randomized, multicenter study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab as first-line (1L) therapy in metastatic microsatellite-stable colorectal cancer (MSS-mCRC)
N. Segal, J. Tie, S. Kopetz, M. Ducreux +12 more
2022Immuno-Oncology and Technology4 citations Open access
Semantic Scholar
407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors
Elaine Shum, A. Daud, M. Reilley, Y. Najjar +19 more
20204 citations Open access
Semantic Scholar
Prognostic implications of TAMs in colorectal cancer hepatic metastases.
M. Reilley, S. Basu, R. Katkhuda, Nicolle L. Patterson +8 more
20174 citations
Semantic Scholar
Clinical and immune responses using anti-CD3 x anti-EGFR bispecific antibody armed T cells (BATs) for locally advanced or metastatic pancreatic cancer.
L. Lum, T. H. Le, M. Choi, A. Thakur +13 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
M. Nardo, M. Gouda, M. Reilley, A. Biter +16 more
2025Journal of Immunotherapy and Precision Oncology2 citations Open access
Semantic Scholar
Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial.
M. Nardo, M. Reilley, A. Biter, Joann Lim +15 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies.
M. Reilley, Ann M. Bailey, V. Subbiah, F. Janku +16 more
20162 citations Open access
Semantic Scholar
Associations between income and survival in cholangiocarcinoma: A comprehensive subtype-based analysis
Calvin X. Geng, Anuragh R. Gudur, Jagannath Kadiyala, Daniel S. Strand +7 more
2024Annals of Hepato-Biliary-Pancreatic Surgery1 citations Open access
Semantic Scholar
Complete response to immunotherapy in a patient with high-risk stage III colorectal cancer after ctDNA-guided detection of early adjuvant treatment failure
Nicholas Lucchesi, Jenna M Ally, M. Reilley
2023Journal for ImmunoTherapy of Cancer1 citations Open access
Semantic Scholar
Associations between context and affect within the daily lives of cancer caregivers
Katharine E. Daniel, J. Glazer, Tri Le, M. Reilley +4 more
2023Supportive Care in Cancer1 citations
Semantic Scholar
1030TiP An open-label multicenter phase Ib study of AN0025, a selective inhibitor of the prostaglandin E2 receptor-type-4 receptor, in combination with pembrolizumab in patients with advanced solid tumors
Wallace A. Akerley, M. Reilley, A. Marabelle, C. Baldini +5 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
Cancer Therapy: Preclinical Activationof4-1BBonLiverMyeloidCellsTriggers Hepatitis via an Interleukin-27–Dependent Pathway
Todd Bartkowiak, A. Jaiswal, C. Ager, Renee L Chin +7 more
20180 citations
Semantic Scholar
Abstract A21: Activation of 4-1BB on liver myeloid cells triggers hepatitis via an interleukin-27 dependent pathway
A. Jaiswal, Todd Bartkowiak, C. Ager, Renee L Chin +7 more
2018Checkpoints and Immunomodulation0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Michael A. Curran×9
Invite
Michael A. Curran — researcher profile on SciRah
D. Hong×9
Invite
D. Hong — researcher profile on SciRah
C. Ager×9
Invite
C. Ager — researcher profile on SciRah
S. Piha-Paul×6
Invite
S. Piha-Paul — researcher profile on SciRah

×6

Invite

A. Naing — researcher profile on SciRah

Todd Bartkowiak×5

Invite

Todd Bartkowiak — researcher profile on SciRah

Invite

A. Jaiswal — researcher profile on SciRah

A. Tsimberidou×5

Invite

A. Tsimberidou — researcher profile on SciRah

Invite

J. Allison — researcher profile on SciRah

Invite

V. Subbiah — researcher profile on SciRah

Invite

S. Fu — researcher profile on SciRah

Invite

S. Bean — researcher profile on SciRah